Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis
RH Matar, CA Than, H Nakanishi… - Blood Coagulation & …, 2022 - journals.lww.com
Abstract AstraZeneca coronavirus disease 2019 (COVID-19) vaccinations have recently
been implicated in thromboembolism formations. Our aim was to investigate the outcomes of
patients with thromboembolic events following the AstraZeneca vaccine (ChAdOx1 nCoV-
19, AZD1222). A literature search was performed from December 2019 to September 2021.
Eligible studies must report participants older than 18 years vaccinated with AstraZeneca
and outcomes of thromboembolic events. Pooled mean or proportion were analyzed using a …
been implicated in thromboembolism formations. Our aim was to investigate the outcomes of
patients with thromboembolic events following the AstraZeneca vaccine (ChAdOx1 nCoV-
19, AZD1222). A literature search was performed from December 2019 to September 2021.
Eligible studies must report participants older than 18 years vaccinated with AstraZeneca
and outcomes of thromboembolic events. Pooled mean or proportion were analyzed using a …